SCHEMBL6203724

SCHEMBL6203724

CC(NC(=O)/C=C/c1ccccc1F)c1cccc(Oc2cccnc2)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ROCK2 O75116 3/20 0.44
▸ ROCK1 Q13464 3/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ PRKG1 Q13976 3/20 0.42
▸ NPC1 O15118 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ RAB9A P51151 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ PRKACA P17612 2/20 0.41
▸ GSK3A P49840 2/20 0.41
▸ GSK3B P49841 2/20 0.41
▸ PRKX P51817 2/20 0.41
▸ CLK4 Q9HAZ1 2/20 0.41
▸ MAP4K4 O95819 1/20 0.41
▸ PRKCG P05129 1/20 0.41
▸ CDK1 P06493 1/20 0.41
▸ RPS6KB1 P23443 1/20 0.41
▸ CDK2 P24941 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6496204 1.00 ROCK2 (0.44) ROCK2ROCK1CYP3A4CYP2C9PRKG1
SCHEMBL6496213 1.00 ROCK2 (0.44) ROCK2ROCK1CYP3A4CYP2C9PRKG1
SCHEMBL6496219 1.00 ROCK2 (0.44) ROCK2ROCK1CYP3A4CYP2C9PRKG1
SCHEMBL31231397 1.00 ROCK2 (0.44) ROCK2ROCK1CYP3A4CYP2C9PRKG1
SCHEMBL6495821 0.93 ROCK1 (0.43) ROCK2ROCK1CYP3A4CYP2C9PRKG1
SCHEMBL6204205 0.93 ROCK1 (0.43) ROCK2ROCK1CYP3A4CYP2C9PRKG1
SCHEMBL6495817 0.93 ROCK1 (0.43) ROCK2ROCK1CYP3A4CYP2C9PRKG1
SCHEMBL6495813 0.93 ROCK1 (0.43) ROCK2ROCK1CYP3A4CYP2C9PRKG1
SCHEMBL6499384 0.91 ROCK1 (0.43) ROCK2ROCK1CYP3A4CYP2C9PRKG1
SCHEMBL6203718 0.91 ROCK1 (0.43) ROCK2ROCK1CYP3A4CYP2C9PRKG1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1581498-A2 PYRIDINYL, PYRIMIDINYL AND PYRAZINYL AMIDES AS POTASSIUM CHANNEL OPENERS Bristol-Myers Squibb Company (US) 2005-10-05 — — EP claimed
WO-2004047739-A2 PYRIDINYL, PYRIMIDINYL AND PYRAZINYL AMIDES AS POTASSIUM CHANNEL OPENERS BRISTOL-MYERS SQUIBB COMPANY (US) 2004-06-10 — — WO claimed
WO-2021113757-A1 USE OF A KV7 POTASSIUM CHANNEL OPENER FOR TREATING PAIN XENON PHARMACEUTICALS INC. (CA) 2021-06-10 — — WO disclosed
EP-1581498-A2 PYRIDINYL, PYRIMIDINYL AND PYRAZINYL AMIDES AS POTASSIUM CHANNEL OPENERS Bristol-Myers Squibb Company (US) 2005-10-05 — — EP disclosed
WO-2004047739-A2 PYRIDINYL, PYRIMIDINYL AND PYRAZINYL AMIDES AS POTASSIUM CHANNEL OPENERS BRISTOL-MYERS SQUIBB COMPANY (US) 2004-06-10 — — WO disclosed
Send feedback